These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9037627)

  • 1. Management of cytomegalovirus infection in solid-organ transplant recipients.
    Murray BM
    Immunol Invest; 1997; 26(1-2):243-55. PubMed ID: 9037627
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytomegalovirus infection in solid organ transplantation.
    Aguado JM; Navarro D; San Juan R; Castón JJ
    Enferm Infecc Microbiol Clin; 2012 Mar; 30 Suppl 2():57-62. PubMed ID: 22542036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late-onset cytomegalovirus disease as a significant complication in solid organ transplant recipients receiving antiviral prophylaxis: a call to heed the mounting evidence.
    Singh N
    Clin Infect Dis; 2005 Mar; 40(5):704-8. PubMed ID: 15714416
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytomegalovirus in solid organ transplant recipients.
    Humar A; Snydman D;
    Am J Transplant; 2009 Dec; 9 Suppl 4():S78-86. PubMed ID: 20070700
    [No Abstract]   [Full Text] [Related]  

  • 5. Counterpoint: prevention of cytomegalovirus (CMV) infection and CMV disease in recipients of solid organ transplants: the case for prophylaxis.
    Snydman DR
    Clin Infect Dis; 2005 Mar; 40(5):709-12. PubMed ID: 15714417
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of cytomegalovirus disease in transplant recipients.
    Pidgeon GB; Bailey RR
    N Z Med J; 1993 Nov; 106(967):468-9. PubMed ID: 8233192
    [No Abstract]   [Full Text] [Related]  

  • 7. Preemptive versus prophylactic approaches in the management of cytomegalovirus disease in solid organ transplant recipients: what we know and what we do not know.
    Meylan PR; Pascual M
    Clin Infect Dis; 2006 Oct; 43(7):881-3. PubMed ID: 16941369
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention and management of cytomegalovirus infection in solid-organ transplantation.
    Mwintshi K; Brennan DC
    Expert Rev Anti Infect Ther; 2007 Apr; 5(2):295-304. PubMed ID: 17402844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus infection in solid organ transplant recipients.
    Lumbreras C; Manuel O; Len O; ten Berge IJ; Sgarabotto D; Hirsch HH
    Clin Microbiol Infect; 2014 Sep; 20 Suppl 7():19-26. PubMed ID: 26451404
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cytomegalovirus infection after solid-organ transplantation, its risk factors, direct and indirect effects and prevention strategies].
    Varga M; Remport A; Czebe K; Péter A; Toronyi E; Sárváry E; Fehérvári I; Sulyok B; Járay J
    Orv Hetil; 2008 Mar; 149(12):551-8. PubMed ID: 18343771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients.
    Rowshani AT; Bemelman FJ; van Leeuwen EM; van Lier RA; ten Berge IJ
    Transplantation; 2005 Feb; 79(4):381-6. PubMed ID: 15729162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of cytomegalovirus following solid organ transplantation: a literature review.
    Kowalsky S; Arnon R; Posada R
    Pediatr Transplant; 2013 Sep; 17(6):499-509. PubMed ID: 23890075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of the prevention of cytomegalovirus disease in solid organ transplant recipients. Introduction.
    Baillie GM
    Am J Health Syst Pharm; 2006 Oct; 63(19 Suppl 5):S2. PubMed ID: 16990641
    [No Abstract]   [Full Text] [Related]  

  • 14. Preemptive therapy of cytomegalovirus disease in pediatric transplant recipients.
    Green M; Michaels M
    Pediatr Infect Dis J; 2000 Sep; 19(9):875-7. PubMed ID: 11001112
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients.
    Roman A; Manito N; Campistol JM; Cuervas-Mons V; Almenar L; Arias M; Casafont F; del Castillo D; Crespo-Leiro MG; Delgado JF; Herrero JI; Jara P; Morales JM; Navarro M; Oppenheimer F; Prieto M; Pulpón LA; Rimola A; Serón D; Ussetti P;
    Transplant Rev (Orlando); 2014 Apr; 28(2):84-91. PubMed ID: 24602805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CMV infection after organ transplantation: immunopathological and clinical aspects.
    The TH; Grefte JM; van der Bij W; van Son WJ; van den Berg AP
    Neth J Med; 1994 Dec; 45(6):309-18. PubMed ID: 7838248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus infection: how to manage it in the immunocompromised transplant recipient?
    Müller GA; Müller CA; Einsele H
    Nephrol Dial Transplant; 1994; 9(1):3-4. PubMed ID: 8177474
    [No Abstract]   [Full Text] [Related]  

  • 18. Etiology and impact of cytomegalovirus disease on solid organ transplant recipients.
    McDevitt LM
    Am J Health Syst Pharm; 2006 Oct; 63(19 Suppl 5):S3-9. PubMed ID: 16990643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients.
    Razonable RR; Paya CV; Smith TF
    J Clin Microbiol; 2002 Mar; 40(3):746-52. PubMed ID: 11880387
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytomegalovirus infection in organ transplant recipients.
    Hibberd PL; Snydman DR
    Infect Dis Clin North Am; 1995 Dec; 9(4):863-77. PubMed ID: 8747770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.